New Therapies in the Treatment of High Cholesterol

William H. Shrank, Jane F. Barlow, Troyen A. Brennan

JAMA · 2015 · 47 citations · 7 references

Concepts

Abstract

This Viewpoint discusses the need to achieve consensus around management strategies for patients with hyperlipidemia when proprotein convertase subtilisin/kexin type 9 (PCSK-9) inhibitors enter the marketplace.

References

7